Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.

Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.

Gardin NE.

Phytother Res. 2009 Mar;23(3):407-11. doi: 10.1002/ptr.2643.

PMID:
19003944
2.

Perioperative application of the Viscum album extract Isorel in digestive tract cancer patients.

Enesel MB, Acalovschi I, Grosu V, Sbarcea A, Rusu C, Dobre A, Weiss T, Zarkovic N.

Anticancer Res. 2005 Nov-Dec;25(6C):4583-90.

3.

Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.

Zuzak TJ, Rist L, Eggenschwiler J, Grotzer MA, Viviani A.

Anticancer Res. 2006 Sep-Oct;26(5A):3485-92.

4.

Immune modulation using mistletoe (Viscum album L.) extracts Iscador.

Büssing A.

Arzneimittelforschung. 2006 Jun;56(6A):508-15. Review.

PMID:
16927532
5.

Immunomodulatory and clinical effects of Viscum album (Iscador M and Iscador P) in children with recurrent respiratory infections as a result of the Chernobyl nuclear accident.

Chernyshov VP, Heusser P, Omelchenko LI, Chernyshova LI, Vodyanik MA, Vykhovanets EV, Galazyuk LV, Pochinok TV, Gaiday NV, Gumenyuk ME, Zelinsky GM, Schaefermeyer H, Schaefermeyer G.

Am J Ther. 2000 May;7(3):195-203.

PMID:
11317168
6.

Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.

Steele ML, Axtner J, Happe A, Kröz M, Matthes H, Schad F.

Integr Cancer Ther. 2015 Mar;14(2):140-8. doi: 10.1177/1534735414563977. Epub 2014 Dec 30.

PMID:
25552476
7.

Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo.

Cebović T, Spasić S, Popović M.

Phytother Res. 2008 Aug;22(8):1097-103. doi: 10.1002/ptr.2464.

PMID:
18570233
8.

Course of mitogen-stimulated T lymphocytes in cancer patients treated with Viscum album extracts.

Büssing A, Stumpf C, Tröger W, Schietzel M.

Anticancer Res. 2007 Jul-Aug;27(4C):2903-10.

10.

Local reactions to treatments with Viscum album L. extracts and their association with T-lymphocyte subsets and quality of life.

Büssing A, Tröger W, Stumpf C, Schietzel M.

Anticancer Res. 2008 May-Jun;28(3B):1893-7.

12.

The efficiency of Viscum album ssp. album and Hypericum perforatum on human immune cells in vitro.

Fidan I, Ozkan S, Gurbuz I, Yesilyurt E, Erdal B, Yolbakan S, Imir T.

Immunopharmacol Immunotoxicol. 2008;30(3):519-28. doi: 10.1080/08923970802135286 .

PMID:
18668395
13.

Review article: Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies.

Kienle GS, Kiene H.

Integr Cancer Ther. 2010 Jun;9(2):142-57. doi: 10.1177/1534735410369673. Epub 2010 May 18. Review.

PMID:
20483874
14.

Effects of European mistletoe (Viscum album L. subsp. album) extracts on activity rhythms of the Syrian hamsters (Mesocricetus auratus).

Karakas A, Turker AU, Gunduz B.

Nat Prod Res. 2008;22(11):996-1006. doi: 10.1080/14786410701654776.

PMID:
18629716
15.
16.

Immunomodulatory effects of Viscum album extracts on natural killer cells: review of clinical trials.

Braedel-Ruoff S.

Forsch Komplementmed. 2010 Apr;17(2):63-73. doi: 10.1159/000288702. Epub 2010 Mar 12. Review.

PMID:
20484913
17.

Cytokine release of a keratinocyte model after incubation with two different Viscum album L extracts.

Gorter RW, Joller P, Stoss M.

Am J Ther. 2003 Jan-Feb;10(1):40-7.

PMID:
12522519
18.

Immunomodulatory effects of iscador: a Viscum album preparation.

Hajto T.

Oncology. 1986;43 Suppl 1:51-65.

PMID:
2433654
19.

[Mistletoe (Viscum album) preparations: an optional drug for cancer patients?].

Bar-Sela G, Gershony A, Haim N.

Harefuah. 2006 Jan;145(1):42-6, 77. Review. Hebrew.

PMID:
16450726
20.

Anaphylactic reactions after therapeutic injection of mistletoe (Viscum album L.).

Hutt N, Kopferschmitt-Kubler M, Cabalion J, Purohit A, Alt M, Pauli G.

Allergol Immunopathol (Madr). 2001 Sep-Oct;29(5):201-3. Review.

PMID:
11720654

Supplemental Content

Support Center